As of 2025-07-14, the Fair Value of Oramed Pharmaceuticals Inc (ORMP) is -3.46 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 2.13 USD, the upside of Oramed Pharmaceuticals Inc is -261.89%.
With the market price of 2.13 USD and our fair value calculation, Oramed Pharmaceuticals Inc (ORMP) is not a good investment. Investing in ORMP stocks now will result in a potential loss of 261.89%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-08-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -22.24 | -11.67 | -36.56 | 5.53 | -19.06 | -16.80 |
| YoY growth | -93.22% | 47.54% | -213.34% | 115.11% | -444.98% | -117.78% |
| Market Cap (mil) | 87.21 |
| P/E | |
| Forward P/E |
| EPS | -0.69 |
| Avg earnings growth rate | -117.78% |
| TTM earnings | -28.24 |